p21-mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress

Molecular Biology of the Cell

Volumn 15, Issue 9, 2004, Pages 3965-3976

  Charrier Savournin, Fabienne Baus ^a,e   Château, Marie Thérèse ^a,b   Gire, Véronique ^a   Sedivy, John ^c   Piette, Jacques ^d   Dulić, Vjekoslav ^a  

^a CNRS   (France)

^b UNIV MONTPELLIER   (France)

^c BROWN UNIVERSITY   (United States)

^d INSERM   (France)

^e CEA Marcoule   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 1; CYCLINE; DNA; PROTEIN KINASE; PROTEIN P21; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL IMMORTALIZATION; CELL LINE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CENTROSOME; DNA DAMAGE; ENZYME ACTIVATION; FIBROBLAST; GENOTOXIC STRESS; GENOTOXICITY; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MALIGNANT TRANSFORMATION; MITOSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; STRESS;

CDC2 PROTEIN KINASE; CDC25 PHOSPHATASE; CELL CYCLE; CELL CYCLE PROTEINS; CELL NUCLEUS; CELLS, CULTURED; CYCLIN B; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; ENZYME ACTIVATION; HUMANS; MITOSIS; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; PHOSPHORYLATION; PROTEIN BINDING;

EID: 4344574113     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E03-12-0871     Document Type: Article

References (48)

1. Aprelikova, O., Xiong, Y., and Liu, E.T. (1995). Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J. Biol. Chem. 270, 18195-18197.
2. Barboule, N., Lafon, C., Chadebech, P., Vidal, S., and Valette, A. (1999). Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition. FEBS Lett. 444, 32-37.
3. Baus, F., Gire, V., Fisher, D., Piette, J., and Dulic, V. (2003). Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts. EMBO J. 22, 3992-4002.
4. Berry, L.D., and Gould, K.L. (1996). Regulation of Cdc2 activity by phosphorylation at T14/Y15. Prog. Cell Cycle Res. 2, 99-105.
5. Borgne, A., and Meijer, L. (1996). Sequential dephosphorylation of p34(cdc2) on Thr-14 and Tyr-15 at the prophase/metaphase transition. J. Biol. Chem. 271, 27847-27854.
6. Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J.P., Sedivy, J.M., Kinzler, K.W., and Vogelstein, B. (1998). Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497-1501.
7. Cans, C., Sert, V., De Rycke, J., Baldin, V., and Ducommun, B. (1999). Use of CDC2 from etoposide-treated cells as substrate to assay CDC25 phosphatase activity. Anticancer Res. 19, 1241-1244.
8. Chan, T.A., Hermeking, H., Lengauer, C., Kinzler, K.W., and Vogelstein, B. (1999). 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 401, 616-620.
9. Chan, T.A., Hwang, P.M., Hermeking, H., Kinzler, K.W., and Vogelstein, B. (2000). Cooperative effects of genes controlling the G(2)/M checkpoint. Genes Dev. 14, 1584-1588.
10. Davis, F.M., Tsao, T.Y., Fowler, S.K., and Rao, P.N. (1983). Monoclonal antibodies to mitotic cells. Proc. Natl. Acad. Sci. USA 80, 2926-2930.
11. De Souza, C.P., Ellem, K.A., and Gabrielli, B.G. (2000). Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events. Exp. Cell Res. 257, 11-21.
12. Deming, P.B., Cistulli, C.A., Zhao, H., Graves, P.R., Piwnica-Worms, H., Paules, R.S., Downes, C.S., and Kaufmann, W.K. (2001). The human decatenation checkpoint. Proc. Natl. Acad. Sci. USA 98, 12044-12049.
13. Downes, C.S., Clarke, D.J., Mullinger, A.M., Gimenez-Abian, J.F., Creighton, A.M., and Johnson, R.T. (1994). A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells. Nature 372, 467-470.
14. Ducommun, B., Brambilla, P., Felix, M.A., Franza, B.R., Jr., Karsenti, E., and Draetta, G. (1991). cdc2 phosphorylation is required for its interaction with cyclin. EMBO J. 10, 3311-3319.
15. Dulic, V., Stein, G.H., Far, D.F., and Reed, S.I. (1998). Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol. Cell. Biol. 18, 546-557.
16. Flatt, P.M., Tang, L.J., Scatena, C.D., Szak, S.T., and Pietenpol, J.A. (2000). p53 regulation of G(2) checkpoint is retinoblastoma protein dependent. Mol. Cell. Biol. 20, 4210-4223.
17. Hagting, A., Jackman, M., Simpson, K., and Pines, J. (1999). Translocation of cyclin B1 to the nucleus at prophase requires a phosphorylation-dependent nuclear import signal. Curr. Biol. 9, 680-689.
18. Hagting, A., Karlsson, C., Clute, P., Jackman, M., and Pines, J. (1998). MPF localization is controlled by nuclear export. EMBO J. 17, 4127-4138.
19. Harper, J.W., et al. (1995). Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6, 387-400.
20. Heald, R., McLoughlin, M., and McKeon, F. (1993). Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell 74, 463-474.
21. Hermeking, H., Lengauer, C., Polyak, K., He, T.C., Zhang, L., Thiagalingam, S., Kinzler, K.W., and Vogelstein, B. (1997). 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1, 3-11.
22. Hirota, T., Kunitoku, N., Sasayama, T., Marumoto, T., Zhang, D., Nitta, M., Hatakeyama, K., and Saya, H. (2003). Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell 114, 585-598.
23. Jackman, M., Lindon, C., Nigg, E.A., and Pines, J. (2003). Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat. Cell Biol. 5, 143-148.
24. Jin, P., Hardy, S., and Morgan, D.O. (1998). Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J. Cell Biol. 141, 875-885.
25. Kaldis, P., Russo, A.A., Chou, H.S., Pavletich, N.P., and Solomon, M.J. (1998). Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities. Mol. Biol. Cell 9, 2545-2560.
26. Levedakou, E.N., Kaufmann, W.K., Alcorta, D.A., Galloway, D.A., and Paules, R.S. (1995). p21CIP1 is not required for the early G2 checkpoint response to ionizing radiation. Cancer Res. 55, 2500-2502.
27. Mikhailov, A., Cole, R.W., and Rieder, C.L. (2002). DNA damage during mitosis in human cells delays the metaphase/anaphase transition via the spindle-assembly checkpoint. Curr. Biol. 12, 1797-1806.
28. Morgan, D.O. (1995). Principles of CDK regulation. Nature 374, 131-134.
29. Munger, K., Basile, J.R., Duensing, S., Eichten, A., Gonzalez, S.L., Grace, M., and Zacny, V.L. (2001). Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20, 7888-7898.
30. Norbury, C., Blow, J., and Nurse, P. (1991). Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J. 10, 3321-3329.
31. Ohi, R., and Gould, K.L. (1999). Regulating the onset of mitosis. Curr. Opin. Cell Biol. 11, 267-273.
32. Passalaris, T.M., Benanti, J.A., Gewin, L., Kiyono, T., and Galloway, D.A. (1999). The G(2) checkpoint is maintained by redundant pathways. Mol. Cell. Biol. 19, 5872-5881.
33. Pines, J., and Hunter, T. (1989). Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 58, 833-846.
34. Pines, J., and Rieder, C.L. (2001). Re-staging mitosis: a contemporary view of mitotic progression. Nat. Cell Biol. 3, E3-E6.
35. Porter, L.A., and Donoghue, D.J. (2003). Cyclin B1 and Cdk 1, nuclear localisation and upstream regulators. Prog. Cell Cycle Res. 5, 335-447.
36. Ren, B., Cam, H., Takahashi, Y., Volkert, T., Terragni, J., Young, R.A., and Dynlacht, B.D. (2002). E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev. 16, 245-256.
37. Roca, J., Ishida, R., Berger, J.M., Andoh, T., and Wang, J.C. (1994). Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. Proc. Natl. Acad. Sci. USA 91, 1781-1785.
38. Rogakou, E.P., Boon, C., Redon, C., and Bonner, W.M. (1999). Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146, 905-916.
39. Saha, P., Eichbaum, Q., Silberman, E.D., Mayer, B.J., and Dutta, A. (1997). p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases. Mol. Cell. Biol. 17, 4338-4345.
40. Smits, V.A., Klompmaker, R., Vallenius, T., Rijksen, G., Makela, T.P., and Medema, R.H. (2000). p21 inhibits thr161 phosphorylation of cdc2 to enforce the G2 DNA damage checkpoint [In Process Citation]. J. Biol. Chem. 275, 30638-30643.
41. Taylor, W.R., and Stark, G.R. (2001). Regulation of the G2/M transition by p53. Oncogene 20, 1803-1815.
42. Toyoshima, F., Moriguchi, T., Wada, A., Fukuda, M., and Nishida, E. (1998). Nuclear export of cyclin B1 and its possible role in the DNA damage-induced G2 checkpoint. EMBO J. 17, 2728-2735.
43. van Hemert, M.J., Steensma, H.Y., and van Heusden, G.P. (2001). 14-3-3 proteins: key regulators of cell division, signalling and apoptosis. Bioessays 23, 936-946.
44. Wei, W., Hemmer, R.M., and Sedivy, J.M. (2001). Role of p14(ARF) in replicative and induced senescence of human fibroblasts. Mol. Cell. Biol. 21, 6748-6757.
45. Westendorf, J.M., Rao, P.N., and Gerace, L. (1994). Cloning of cDNAs for M-phase phosphoproteins recognized by the MPM2 monoclonal antibody and determination of the phosphorylated epitope. Proc. Natl. Acad. Sci. USA 91, 714-718.
46. Winters, Z.E., Ongkeko, W.M., Harris, A.L., and Norbury, C.J. (1998). p53 regulates Cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cells. Oncogene 17, 673-684.
47. Yang, J., Bardes, E.S., Moore, J.D., Brennan, J., Powers, M.A., and Kornbluth, S. (1998). Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1. Genes Dev. 12, 2131-2143.
48. Yang, J., Song, H., Walsh, S., Bardes, E.S., and Kornbluth, S. (2001). Combinatorial control of cyclin B1 nuclear trafficking through phosphorylation at multiple sites. J. Biol. Chem. 276, 3604-3609.